Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imide Derivatives. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104974135B details potent naphthalimide-celecoxib hybrids. We offer scalable synthesis for high-purity anticancer intermediates with optimized supply chain reliability.
Patent CN103242312B reveals high-yield copper-catalyzed route for organic semiconductors. Reduces cost and improves supply chain reliability for electronic chemical manufacturing.
Novel copper-catalyzed Bunte salt thioamination for high-purity maleimide intermediates. Reduces odor and cost in pharma manufacturing.
Patent CN111440109A details a novel copper-catalyzed route using Bunte salts for high-purity maleimide intermediates, offering significant cost and supply chain advantages.
Patent CN108707081B discloses a mild photocatalytic method for olefin difunctionalization, offering cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Novel glucose triazole maleimide synthesis via 1,3-dipolar cycloaddition. Enhances solubility and tumor inhibition. Reliable supply chain for pharma intermediates.
Patent CN103833734B details a novel fungicidal intermediate synthesis from turpentine. Offers cost-effective, scalable production for agrochemical supply chains.
Patent CN111548298B details a novel organocatalytic route for chiral trifluoromethyl maleimides, offering high stereoselectivity and simplified supply chains for pharmaceutical intermediates.
Novel NHC-catalyzed desymmetrization route for high-purity rolipram intermediates offering significant cost and supply chain advantages.
Novel copper-catalyzed radical tandem reaction for high-purity intermediates. Reduces waste and cost in pharmaceutical manufacturing via efficient amine hydrochloride utilization.
Patent CN118600444A enables green electrochemical synthesis. Reduces cost and improves supply chain reliability for phosphorimide derivatives manufacturing processes.
Patent CN118600444A reveals oxidant-free electrochemical route. Delivers high-purity phosphorimide derivatives with reduced operational costs and enhanced supply chain reliability.
Novel synthesis of red-emitting perylene bisimides via amidation and coupling. Offers high quantum yield and scalable production for optoelectronics.
Patent CN101289447B details a novel copper-catalyzed route for stable, soluble organic semiconductors, offering significant cost reduction and supply chain reliability.
Patent CN102532030A reveals a mercury-free synthesis route for 2-iminoimidazoline-4,5-dione derivatives, offering high purity and scalable production for agrochemical and pharmaceutical applications.
Patent CN108558968B reveals novel antitumor intermediates with enhanced solubility. Streamlined synthesis offers supply chain stability and cost efficiency for global pharmaceutical manufacturing.
Novel Lewis acid-promoted [4+2] cyclization for 3,4-pyridinediimides. High atom economy, wide substrate scope, ideal for API and functional material manufacturing.
Patent CN114989032B reveals a catalyst-free, visible-light driven synthesis for imide derivatives, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN107698648B reveals a novel synthesis for cholesterol-naphthalimide hybrids with anticancer and liquid crystal applications, offering scalable routes for high-purity intermediates.
Patent CN112795943A details a green electrochemical method for 3,4-dibromomaleimide, offering cost reduction in API manufacturing and enhanced supply chain reliability.